Role of molecular markers in the management of head and neck cancers
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of molecular markers in the management of head and neck cancers
Authors
Keywords
-
Journal
CURRENT OPINION IN ONCOLOGY
Volume 23, Issue 3, Pages 259-264
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-02-25
DOI
10.1097/cco.0b013e328344f53a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Examining the association between socioeconomic status and potential human papillomavirus-associated cancers
- (2010) Vicki B. Benard et al. CANCER
- Human papillomavirus status in head and neck cancer
- (2010) Andrew G. Shuman et al. CANCER
- New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
- (2010) L. F. Chen et al. CLINICAL CANCER RESEARCH
- Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents
- (2010) KJ Harrington et al. INDIAN JOURNAL OF CANCER
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing
- (2010) Max Robinson et al. ORAL ONCOLOGY
- Low prevalence of Human Papillomavirus in oral cavity carcinomas
- (2010) Jerry Machado et al. Head and Neck Optical Diagnostics Society
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications
- (2009) C. H. Chung et al. CLINICAL CANCER RESEARCH
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium
- (2009) Julia E Heck et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel
- (2009) Juan J. Grau et al. LARYNGOSCOPE
- HPV & head and neck cancer: a descriptive update
- (2009) Peter KC Goon et al. Head and Neck Optical Diagnostics Society
- ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
- (2008) H J Jun et al. BRITISH JOURNAL OF CANCER
- A Personalized Approach to Cancer Treatment: How Biomarkers Can Help
- (2008) M. J. Duffy et al. CLINICAL CHEMISTRY
- Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition
- (2008) Alexandre Bozec et al. EUROPEAN JOURNAL OF CANCER
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells
- (2007) Masayasu Iwase et al. ORAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now